Arş. Gör. Dr. MERVE AKKULAK

Yayın Ağı

Makaleler 6

1. Modulation of Caco-2 Colon Cancer Cell Viability and CYP2W1 Gene Expression by Hesperidin-treated Lacticaseibacillus rhamnosus GG (LGG) Cell-free Supernatants.

Akkulak M., Evin E., Durukan O., Celebioglu H. U., Adali O.

Anti-cancer agents in medicinal chemistry , cilt.24, ss.372-378, 2024 (SCI-Expanded, Scopus)

2. Xenogenic Neural Stem Cell-Derived Extracellular Nanovesicles Modulate Human Mesenchymal Stem Cell Fate and Reconstruct Metabolomic Structure

DERKUŞ B., Isik M., Eylem C. C., ERGİN İ., Camci C. B., Bilgin S., et al.

ADVANCED BIOLOGY , cilt.6, sa.6, 2022 (SCI-Expanded)

3. Association of cholesterol 7α-hydroxylase (CYP7A1) promoter polymorphism (rs3808607) and cholesterol 24S-hydroxylase (CYP46A1) intron 2 polymorphism (rs754203) with serum lipids, vitamin D levels, and multiple sclerosis risk in the Turkish population

SEZER E., CAN DEMİRDÖĞEN B., Demirkaya S., Bulut G., AKKULAK M., EVİN E., et al.

Neurological Sciences , cilt.43, sa.4, ss.2611-2620, 2022 (SCI-Expanded, Scopus)

4. Effect of cisplatin treatment on protein expression of vitamin D metabolizing CYP24A1 in PC3 cell line

EVİN E., Durukan O., AKKULAK M., ADALI O.

FEBS OPEN BIO , cilt.8, ss.326, 2018 (SCI-Expanded, Scopus)

5. Effect of quercetin on mRNA and protein expressions of vitamin D metabolizing CYP27B1 and CYP24A1 in human embryonic kidney cell line (HEK-293)

Akkulak M., Evin E., Durukan Ö., Özhan G., Adalı O.

FEBS OPEN BIO , cilt.8, ss.352, 2018 (SCI-Expanded, Scopus)

6. Alteration of protein and gene expressions of Hexokinase II in PC3 cell lines by cisplatinmetformin combination treatment

Durukan Ö., Akkulak M., Evin E., Arslan Ş., Adalı O.

FEBS OPEN BIO , cilt.8, ss.352, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 9

1. CYP2W1 geninin tümörigenezde anjiyojenik potansiyeli

Akkulak M., Adalı O., Durukan Ö.

FEBS2023, Tours, Fransa, 8 - 12 Temmuz 2023, ss.74, (Özet Bildiri)

2. CYP2W1 geninin tümörijenezde anjiyojenik potansiyeli

Akkulak M., Adalı O., Durukan Ö.

FEBS2023, Tours, Fransa, 8 - 12 Temmuz 2023, ss.74, (Özet Bildiri)

3. ONKOFETAL CYP2W1 GENİNİN EPİTELYAL-MEZENKİMAL GEÇİŞ BELİRTEÇLERİ ÜZERİNE ETKİLERİ

Akkulak M., Durukan Ö., Evin E., Adalı O.

International Biochemistry Congreess 2022, İzmir, Türkiye, 26 - 30 Ekim 2022, cilt.50, sa.49, ss.136-137, (Özet Bildiri)

4. Investigating the role of CYP4X1 gene during brain tumor angiogenesis via RNAi mediated gene repression

Durukan Ö., Akkulak M., Evin E., Adalı O.

TBS International Biochemistry Congress 2022 - 33th National Biochemistry Congress, İzmir, Türkiye, 26 - 30 Ekim 2022, cilt.50, sa.50, ss.137, (Özet Bildiri)

5. Analysis of Protein and mRNA Expressions of CYP1A1 and CYP2E1 Enzymes In Liver, Colon And Prostate Cancer Cell Lines to Study Drug and Carcinogen Metabolism

Evin E., Karakurt S., Akkulak M., Adalı O.

International Congress on Advances in BioScience and Biotechnology, Sarajevo, Bosna-Hersek, 25 - 29 Ekim 2017, ss.59, (Özet Bildiri) Sürdürülebilir Kalkınma

6. Effect of resveratrol on mRNA and protein expressions of Vitamin D metabolizing CYP24A1 in human embryonic kidney cell line (HEK-293)

AKKULAK M., EVİN E., DURUKAN Ö., ÖZHAN H. G., ADALI O.

10th International Symposium on Health Informatics and Bioinformatics (HIBIT 2017), 28 - 30 Haziran 2017, (Özet Bildiri)